2-acetylaminofluorene has been researched along with tamoxifen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Chou, MC; Chung, JG; Hsia, TC; Hsiao, YM; Hung, CF; Lin, KL; Lu, KH | 1 |
2 other study(ies) available for 2-acetylaminofluorene and tamoxifen
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Tamoxifen inhibits arylamine N-acetyltransferase activity and DNA-2-aminofluorene adduct in human leukemia HL-60 cells.
Topics: 2-Acetylaminofluorene; Arylamine N-Acetyltransferase; Carcinogens; DNA Adducts; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Tamoxifen | 2001 |